Cargando…
Determination of Extravasation Effects of Nal-Iri and Trabectedin and Evaluation of Treatment Options for Trabectedin Extravasation in a Preclinical Animal Model
Background: Extravasation during chemotherapy administration can lead to dangerous adverse effects ranging from pain to tissue necrosis. Evidence-based data about prevention and treatment of extravasation injuries of some clinically used compounds still remains elusive. This work aimed to investigat...
Autores principales: | Keritam, Omar, Juhasz, Viktoria, Schöfer, Christian, Thallinger, Christiane, Aretin, Marie-Bernadette, Schabbauer, Gernot, Breuss, Johannes, Unseld, Matthias, Uhrin, Pavel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204062/ https://www.ncbi.nlm.nih.gov/pubmed/35721106 http://dx.doi.org/10.3389/fphar.2022.875695 |
Ejemplares similares
-
Trabectedin in Soft Tissue Sarcomas
por: Petek, Bradley J., et al.
Publicado: (2015) -
Trabectedin for soft tissue sarcoma
Publicado: (2021) -
Advanced soft-tissue sarcoma and treatment options: critical appraisal of trabectedin
por: Desar, Ingrid M E, et al.
Publicado: (2016) -
Diagnosis and treatment of ALT tumors: is Trabectedin a new therapeutic option?
por: Pompili, Luca, et al.
Publicado: (2017) -
The Role of Trabectedin in Soft Tissue Sarcoma
por: Nakamura, Tomoki, et al.
Publicado: (2022)